Alcon Inc

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

ALC

Financials

Alcon Inc

Noticias

Is it a Prudent Move to Retain IDXX Stock in Your Portfolio Now?

Are Medical Stocks Lagging Alcon (ALC) This Year?

National Vision Gains 116.9% in a Year: What's Driving the Rally?

Top Research Reports for Bank of America, GE Aerospace & T-Mobile

Is This the Right Time to Add Globus Medical Stock to Your Portfolio?

Alcon Stock Gains Following the Launch of Clareon TruPlus at ASCRS

Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases (NYSE:ALC)

BYND And LNSR Set The Tone Tuesday

Alcon Buy Rating Reaffirmed, Despite Failed STAAR Merger, As Eyecare Portfolio Leads

Alcon terminates LENSAR acquisition after FTC opposition

Top Research Reports for Philip Morris, Lam Research & Goldman Sachs

Aurion Biotech names Dr. Marjan Farid as advisory board chair